BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:38 PM
 | 
Jul 11, 2008
 |  BC Extra  |  Company News

Momenta gains on Copaxone challenge

Momenta (NASDAQ:MNTA) gained $0.81 to $13.89 on Friday after FDA accepted for review an ANDA from Momenta partner Sandoz for a generic version of glatiramer. Teva (NASDAQ:TEVA)...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >